The M-MDSC were upregulated in patients (p < 0.0001) and were correlated with CLL tumor progression, poor prognosis, and correlated with the presence of CD4+ T and CD5+CD19+ cells. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.